Immunotherapy Cell Harvesting Technologies: Enabling the Next Era of Cell-Based Cancer Treatment

Immunotherapy cell harvesting technologies are emerging as a critical foundation of modern cell-based therapies, particularly in oncology and regenerative medicine. These advanced systems are designed to efficiently isolate, collect, and process immune cells—such as T cells, natural killer (NK) cells, and stem cells—from biological samples for use in personalized immunotherapy treatments. As cancer care shifts toward precision medicine, the ability to harvest high-quality, viable cells has become essential for ensuring therapeutic success.

The global cell harvesting systems market was valued at approximately USD 6.02 billion in 2024. It is projected to increase from USD 6.87 billion in 2025 to around USD 22.98 billion by 2034, growing at a CAGR of 14.3% during 2025–2034, driven by rising demand for advanced cell-based therapies and biotechnology applications.

Role of Cell Harvesting in Immunotherapy

Cell harvesting is a foundational step in immunotherapy workflows, especially for therapies such as CAR-T cell therapy, dendritic cell therapy, and NK cell therapy. The process involves collecting immune cells from a patient or donor, followed by isolation, purification, and preparation for genetic modification or expansion.

These harvested cells are then engineered or activated in laboratory settings to recognize and destroy cancer cells more effectively when reintroduced into the patient. The quality and viability of harvested cells directly influence treatment outcomes, making advanced harvesting technologies essential for clinical success.

Key Immunotherapy Cell Harvesting Technologies

1. Automated Cell Harvesting Systems

Automated platforms are increasingly replacing manual methods due to their precision, scalability, and reduced risk of contamination. These systems use robotics and integrated sensors to streamline cell collection and separation processes, ensuring consistent cell quality for downstream therapeutic use.

Automation also supports large-scale CAR-T manufacturing, where reproducibility and efficiency are critical for commercial viability.

2. Closed-System Cell Processing Technologies

Closed systems are designed to maintain sterile conditions throughout the entire harvesting process. This significantly reduces the risk of microbial contamination and aligns with strict regulatory requirements in cell therapy manufacturing.

These systems are especially important for autologous therapies, where patient-derived cells must be processed under highly controlled conditions to ensure safety and effectiveness.

3. Apheresis-Based Cell Collection

Apheresis technology plays a key role in immunotherapy by separating specific immune cells directly from blood. Leukapheresis, for example, is widely used in CAR-T cell therapy to collect T lymphocytes for further modification.

This method allows selective extraction of target cells while returning other blood components to the patient.

Market Overview: Cell Harvesting Systems Market

The Cell Harvesting Systems Market is experiencing strong growth due to rising demand for cell-based therapies, increasing prevalence of chronic diseases, and rapid advancements in biotechnology. The market is projected to grow significantly over the coming decade, driven by expansion in immunotherapy applications and increasing investment in personalized medicine.

Key growth drivers include:

• Expanding adoption of CAR-T and other cell-based immunotherapies
• Rising prevalence of cancer and autoimmune diseases
• Increasing demand for automated and closed-system solutions
• Growing investments in stem cell research and regenerative medicine
• Technological advancements in bioprocessing and cell isolation

The market is also witnessing a shift toward automation and digital integration, enabling more efficient and scalable production of therapeutic cells.

Segment Analysis

By Technology

• Automated cell harvesting systems
• Manual cell harvesting systems
• Apheresis-based systems
• Magnetic and microfluidic systems

Automated systems dominate due to their ability to improve efficiency, reduce human error, and support large-scale immunotherapy production.

By Application

• CAR-T cell therapy
• Stem cell therapy
• Cancer immunotherapy
• Regenerative medicine
• Clinical research and diagnostics

CAR-T cell therapy represents one of the fastest-growing application segments, driven by increasing regulatory approvals and clinical success rates.

By End User

• Biopharmaceutical companies
• Research institutes
• Hospitals and clinical laboratories
• Contract development and manufacturing organizations (CDMOs)

Biopharmaceutical companies are the primary end users due to their involvement in large-scale therapeutic manufacturing.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/cell-harvesting-systems-market

List of Key Companies 

• PerkinElmer, Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Thermo Fisher Scientific, Inc.
• GE HealthCare Technologies, Inc.
• Terumo Corporation
• STEMCELL Technologies Inc.
• Miltenyi Biotec
• Corning Incorporated
• Merck KGaA
• Lonza Group AG
• PromoCell GmbH
• Bio-Rad Laboratories, Inc.
• Nikon Corporation (Healthcare Business Unit)
• Charles River Laboratories International, Inc.

Regional Analysis

North America

North America dominates the market due to advanced healthcare infrastructure, strong biotech ecosystems, and early adoption of immunotherapy technologies.

Europe

Europe is a key region driven by strong clinical research networks and supportive regulatory frameworks for advanced cell therapies.

Asia Pacific

Asia Pacific is the fastest-growing region due to increasing investment in biotechnology, expanding clinical trials, and growing cancer burden in countries like China, Japan, and India.

Latin America and Middle East & Africa

These regions are gradually adopting immunotherapy technologies, supported by improving healthcare infrastructure and rising awareness of advanced cancer treatments.

Key Growth Drivers

• Rising global cancer incidence
• Expansion of personalized medicine approaches
• Increasing clinical adoption of CAR-T therapies
• Technological advancements in automated cell processing
• Growing demand for contamination-free manufacturing systems

Future Outlook

The future of immunotherapy cell harvesting technologies is highly promising, with continued innovation expected in automation, microfluidics, and closed-system bioprocessing. As immunotherapy becomes a mainstream cancer treatment option, demand for efficient and scalable cell harvesting platforms will continue to rise.

The Cell Harvesting Systems Market will remain a key enabler of this transformation, supporting the development of next-generation cell therapies and advancing global efforts toward precision oncology and regenerative medicine.

More Trending Latest Reports By Polaris Market Research:

Liver Cancer Market

Artificial Intelligence in Precision Medicine Market

Next-generation Sequencing Library Preparation Market

Cell And Gene Therapy Clinical Trials Market

Platinum-Based Cancer Drugs Market

Transplant Monitoring Kits Market

Castrate-Resistant Prostate Cancer Market

Japan Neurology Clinical Trials Market